Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
07. Oktober 2024 08:30 ET
|
Impact BioMedical, Inc.
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare...
Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue
26. September 2024 08:30 ET
|
Impact BioMedical, Inc.
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
17. September 2024 11:29 ET
|
Impact BioMedical, Inc.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the...
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
16. September 2024 10:24 ET
|
Impact BioMedical, Inc.
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the...
Impact Biomedical Inc. Files Current Report on Form 8-K
15. November 2023 13:57 ET
|
Impact BioMedical, Inc.
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. (“the Company” and “Impact”) announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange...